Placenta
Volume 28, Issue 5 , Pages 369-377 , May 2007

Magnetic Resonance Spectroscopy of the Placenta

,Accepted 23 May 2006.

References 

  1. Henriksen O. MR spectroscopy in clinical research. Acta Radiol. 1994;35:96–116
  2. Wicks JD, Matwiyoff NA. Stable isotopes and magnetic resonance spectroscopy: general considerations and experimental and operational aspects. In:  Mettler FA,  Muroff LR,  Kulkarni MV editor. Magnetic resonance imaging and spectroscopy. New York: Churchill Livingstone; 1986;p. 245–261
  3. Matwiyoff NA, Wicks JD. Stable isotopes and magnetic resonance spectroscopy: studies of animal models and humans. In:  Mettler FA,  Muroff LR,  Kulkarni MV editor. Magnetic resonance imaging and spectroscopy. New York: Churchill Livingstone; 1986;p. 263–277
  4. Bottomley PA. The rise of human in vivo NMR spectroscopy. Solid State Nucl Magn Reson. 1997;9:29–40
  5. Serkova N, Bendrick-Peart J, Alexander B, Tissot van Patot MC. Metabolite concentrations in human term placentae and their changes due to delayed collection after delivery. Placenta. 2003;24:227–235
  6. Kay HH, Hawkins SR, Gordon JD, Wang Y, Ribeiro AA, Spicer LD. Comparative analysis of normal and growth-retarded placentas with phosphorus nuclear magnetic resonance spectroscopy. Am J Obstet Gynecol. 1992;167:548–553
  7. Bloxam DL. Human placental energy metabolism: its relevance to in vitro perfusion. Contrib Gynecol Obstet. 1985;13:59–69
  8. Kay HH, Gordon JD, Wang Y, Ribeiro AA, Spicer LD. Phosphorus 31 magnetic resonance spectroscopy of human placenta and quantitation with perchloric acid extracts. Am J Obstet Gynecol. 1991;164:80–87
  9. Pulkkinen MO, Nyman S, Hamalainen MM, Mattinen J. Proton NMR spectroscopy of the phospholipids in human uterine smooth muscle and placenta. Gynecol Obstet Invest. 1998;46:220–224
  10. Noyszewski EA, Raman J, Trupin SR, McFarlin BL, Dawson MJ. Phosphorus 31 nuclear magnetic resonance examination of female reproductive tissues. Am J Obstet Gynecol. 1989;161:282–288
  11. Kay HH, Hawkins SR, Wang Y, Mika DE, Ribeiro AA, Spicer LD. Phosphorus 31 magnetic resonance spectroscopy of perifused human placental villi under varying oxygen concentrations. Am J Obstet Gynecol. 1993;168:246–252
  12. Malek A, Miller RK, Mattison DR, Ceckler T, Panigel M, di Sant'Agnese PA, et al. Continuous measurement of ATP by 31P NMR in term human dually perfused placenta in vitro: response to ischemia. J Appl Physiol. 1995;78:1778–1786
  13. Matson GB, Weiner MW. Spectroscopy. In:  Stark DD,  Bradley WG editor. Magnetic resonance imaging. St. Louis: Mosby; 1999;p. 181–194
  14. Pulkkinen MO, Hamalainen MM, Nyman S, Pihlaja K, Mattinen J. Tissue phospholipids during human pregnancy by 31P NMR: myometrium, decidua, placenta and fetal membranes. NMR Biomed. 1996;9:53–58
  15. Dawson MJ, McFarlane DK, McFarlin BL, Noyszewski EA, Trupin SR. The biochemistry of female reproductive tissues studied by phosphorus nuclear magnetic resonance spectroscopy: effects of pregnancy, hormonal manipulation, and disease. Biol Reprod. 1988;38:31–38
  16. Malek A, Miller RK, Mattison DR, Kennedy S, Panigel M, di Sant'Agnese PA, et al. Energy charge monitoring via magnetic resonance spectroscopy 31P in the perfused human placenta: effects of cadmium, dinitrophenol and iodoacetate. Placenta. 1996;17:495–506
  17. Dobbins RL, Malloy CR. Measuring in-vivo metabolism using nuclear magnetic resonance. Curr Opin Clin Nutr Metab Care. 2003;6:501–509
  18. Weindling AM, Griffiths RD, Garden AS, Martin PA, Edwards RH. Phosphorus metabolites in the human placenta estimated in vivo by magnetic resonance spectroscopy. Arch Dis Child. 1991;66:780–782

PII: S0143-4004(06)00131-7

doi: 10.1016/j.placenta.2006.05.008

Placenta
Volume 28, Issue 5 , Pages 369-377 , May 2007

Article Tools

* Image Usage & Resolution